The company declared the results after market hours on Monday, 14 November 2011.
Meanwhile, the BSE Sensex was up 27.22 points, or 0.16% to 17,145.96.
On BSE, 94,000 shares were traded in the counter as against average daily volume of 1.01 lakh shares in the past one quarter.
The stock hit a high of Rs 300.70 and a low of Rs 295 so far during the day. The stock had hit a 52-week low of Rs 273.60 on 6 September 2011. The stock had hit a record high of Rs 380.80 on 4 January 2011.
The stock had performed inline with the market over the past one month till 14 November 2011, gaining 0.21% compared with the Sensex's 0.21% return. The stock had, however, underperformed the market in past one quarter, declining 1.74% as against Sensex's rise of 1.66%.
The large-cap pharma firm has equity capital of Rs 160.58 crore. Face value per share is Rs 2.
Cipla manufactures pharmaceutical products. The products of the company include anti-asthmatics, anti-cancer, anti-inflammatory, anti-depressant and other therapeutic products including animal health care products.